Gene expression signature for wnt/b-catenin signaling pathway and use thereof
OwnerZhong Wu, John DiCarlo +1inventors
InventorsZhong Wu, John DiCarlo, Yexun Wang
Life of this patent
Estimating the term…
Loading patent…
OwnerZhong Wu, John DiCarlo +1inventors
InventorsZhong Wu, John DiCarlo, Yexun Wang
Estimating the term…
The present invention relates to a novel set of 16 biomarkers, microarrays that provide for the detection thereof, an expression signature comprising 16 genes or a subset thereof, and the use thereof in determining the regulation status of Wnt/β-catenin signaling pathway. The regulation status of Wnt/β-catenin signaling pathway may be assayed based on the level of expression of one or more of these genes. The expression of these biomarkers may be used to evaluate Wnt/β-catenin pathway deregulation status; classify a cell sample as having a deregulated or regulated Wnt/β-catenin signaling pathway; determine whether an agent modulates the Wnt/β-catenin signaling pathway; predict response of a subject to an agent that modulates the Wnt/β-catenin signaling pathway; assign treatment to a subject; or evaluate the pharmacodynamic effects of therapies designed to regulate Wnt/β-catenin pathway signaling.
A microarray composition for effecting amplification analysis of a sample to detect the regulation status of Wnt/β-catenin signaling pathway in a cell sample or subject, wherein the composition comprises sequences that amplify and provide for the detection of at least 5 of the genes selected from the group consisting of CALM1, CCND1, CCND2, CHSY1, CXADR, CYP4V2, FAM44B, HSPA12A, LEF1, MTP18, MYC, NAV2, SKP2, PRMT6, MTSS1 and MT1A or an ortholog or variant thereof.
(canceled)
(canceled)
(canceled)
A method of determining the regulation status of Wnt/β-catenin signaling pathway in a cell sample or subject comprising detecting and comparing the expression of one or more of the genes selected from the group consisting of CALM1, CCND1, CCND2, CHSY1, CXADR, CYP4V2, FAM44B, HSPA12A, LEF1, MTP18, MYC, NAV2, SKP2, PRMT6, MTSS1 and MT1A. to the expression of the same genes by a control cell sample and based on this comparison determining the regulation status of the Wnt/β-catenin signaling pathway in a cell sample or subject.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.